China Universal Asset Management Company’s BioAtla BCAB Stock Holding History

China Universal Asset Management Company’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-24	Closed	-$2.07K	–	435
2023 Q3	$2.07K	Buy	24 +11	+85%	+$1.4K	﹤0.01%	432
2023 Q2	$1.88K	Hold	13	–	–	﹤0.01%	429
2023 Q1	$1.68K	Buy	13 +4	+44%	+$720	﹤0.01%	437
2022 Q4	$3.87K	Buy	9 +2	+29%	+$830	﹤0.01%	326
2022 Q3	$3K	Buy	+7	New	+$2.29K	﹤0.01%	321

Other funds holding BCAB

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

China Universal Asset Management Company's BCAB Position: Q4 2023 in Review

China Universal Asset Management Company sold out of BioAtla (BCAB) in Q4 2023, closing a stake of 24 shares — an estimated $2.07K sold.

China Universal Asset Management Company first reported a position in BCAB in Q3 2022 and held it in 5 quarters. The position peaked at $3.87K in Q4 2022. 79 funds tracked by Wall St. Rank hold BCAB as of Q4 2023.

China Universal Asset Management Company reported no remaining BioAtla position as of Q4 2023 after selling out during the quarter.
China Universal Asset Management Company sold 24 BioAtla shares in Q4 2023, an estimated $2.07K.
China Universal Asset Management Company first reported a position in BioAtla in Q3 2022 and held it in 5 quarters.
China Universal Asset Management Company's BioAtla position peaked at $3.87K in Q4 2022.
79 funds tracked by Wall St. Rank held BioAtla as of Q4 2023.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.